| An oral methionine aminopeptidase II inhibitor for high-risk non-muscle invasive bladder cancer relapsed after intravesical therapies: Update of a phase II trial | |
| null | |
| 刊名 | Journal of Clinical Oncology
 |
| 2017 | |
| 卷号 | 35 |
| ISSN号 | 0732-183X |
| URL标识 | 查看原文 |
| 语种 | 英语 |
| 内容类型 | 期刊论文 |
| URI标识 | http://www.corc.org.cn/handle/1471x/3619283 |
| 专题 | 复旦大学上海医学院 |
| 推荐引用方式 GB/T 7714 | null. An oral methionine aminopeptidase II inhibitor for high-risk non-muscle invasive bladder cancer relapsed after intravesical therapies: Update of a phase II trial[J]. Journal of Clinical Oncology,2017,35. |
| APA | null.(2017).An oral methionine aminopeptidase II inhibitor for high-risk non-muscle invasive bladder cancer relapsed after intravesical therapies: Update of a phase II trial.Journal of Clinical Oncology,35. |
| MLA | null."An oral methionine aminopeptidase II inhibitor for high-risk non-muscle invasive bladder cancer relapsed after intravesical therapies: Update of a phase II trial".Journal of Clinical Oncology 35(2017). |
| 个性服务 |
| 查看访问统计 |
| 相关权益政策 |
| 暂无数据 |
| 收藏/分享 |
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
修改评论